TWINLAB CORP
8-K, 1997-04-16
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: STRAYER EDUCATION INC, S-1/A, 1997-04-16
Next: AETNA VARIABLE PORTFOLIOS INC, NSAR-B/A, 1997-04-16



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15 (d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                DATE OF REPORT (Date of earliest event reported):
                                 April 15, 1997
                                   ----------

                               TWINLAB CORPORATION
             (Exact name of registrant as specified in its charter)

            DELAWARE                       0-21003              11-3317986
- --------------------------------------------------------------------------------
(State or other jurisdiction of   (Commission file number)   (I.R.S. employer
 incorporation or organization)                             identification no.)


           2120 SMITHTOWN AVENUE,
               RONKONKOMA, NY                               11779 
- --------------------------------------------------------------------------------
  (Address of principal executive offices)               (Zip code)


       REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (516) 467-3140


<PAGE>

Item 5.  Other Events.

         The Board of  Directors  of Twinlab  Corporation  (the  "Company")  has
rescheduled the Company's  Annual Meeting of  Stockholders  for 10:00 A.M., June
17, 1997, at the Marriott Wind Watch Hotel in Hauppauge, New York.

         Pursuant  to a  unanimous  written  consent of the Board of  Directors,
dated  April 15,  1997,  the Board fixed the close of business on May 9, 1997 as
the record date for the  determination of the  stockholders  entitled to receive
notice of and to vote at the Annual Meeting or any adjournments thereof.


<PAGE>

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                                     TWINLAB CORPORATION


                                                     By:/s/ Ross Blechman 
                                                        ----------------- 
                                                        Ross Blechman
                                                        Chairman of the Board,
                                                        President and Chief
                                                        Executive Officer


                                                        Date:  April 16, 1997




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission